Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China flag China · Delayed Price · Currency is CNY
48.43
-1.75 (-3.49%)
May 14, 2026, 3:04 PM CST

SHE:300832 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
4,5754,5714,5273,9203,0402,539
Other Revenue
6.086.088.29.916.476.17
4,5814,5774,5353,9303,0472,545
Revenue Growth (YoY)
-1.25%0.91%15.42%28.97%19.70%15.97%
Cost of Revenue
1,3471,4071,2671,064906.2734.3
Gross Profit
3,2343,1703,2692,8662,1411,811
Selling, General & Admin
864.06863.66839.96736.09463.67537.29
Research & Development
483.17477.77453.59366.05317.71215.05
Other Operating Expenses
57.6937.561615.2512.498.57
Operating Expenses
1,4161,3971,3361,128807.89753.54
Operating Income
1,8181,7731,9331,7391,3331,058
Interest Expense
-0.5-0.53-0.42-0.43-0.27-0.15
Interest & Investment Income
113.2493.47108.1689.866.7656.6
Currency Exchange Gain (Loss)
-14.66-14.6618.6417.7168.98-31.3
Other Non Operating Income (Expenses)
-55.53-5.02-3.37-2.83-2.23-1.43
EBT Excluding Unusual Items
1,8611,8462,0561,8431,4661,081
Gain (Loss) on Sale of Investments
17.1719.7728.9418.5515.6218.76
Gain (Loss) on Sale of Assets
-0.210.030.040.050.620.1
Asset Writedown
-1.67-1.67-0.43-1.52-1.52-1.86
Other Unusual Items
-7.98-9.119.133.2320.3837.24
Pretax Income
1,8681,8552,0931,8931,5011,136
Income Tax Expense
243.09235.01264.74239.41173.28161.83
Net Income
1,6251,6201,8281,6541,328973.7
Net Income to Common
1,6251,6201,8281,6541,328973.7
Net Income Growth
-11.69%-11.39%10.57%24.53%36.38%3.68%
Shares Outstanding (Basic)
786786786785785784
Shares Outstanding (Diluted)
786786786786786786
Shares Change (YoY)
-0.00%0.00%-0.01%-0.07%0.04%4.76%
EPS (Basic)
2.072.062.332.111.691.24
EPS (Diluted)
2.072.062.332.101.691.24
EPS Growth
-11.68%-11.39%10.59%24.61%36.32%-1.03%
Free Cash Flow
1,5201,211917.241,096559.17430.28
Free Cash Flow Per Share
1.931.541.171.400.710.55
Dividend Per Share
1.2001.2001.3001.0000.7000.600
Dividend Growth
-7.69%-7.69%30.00%42.86%16.67%-54.40%
Gross Margin
70.60%69.25%72.07%72.93%70.26%71.15%
Operating Margin
39.69%38.74%42.61%44.24%43.74%41.55%
Profit Margin
35.47%35.40%40.31%42.08%43.58%38.25%
Free Cash Flow Margin
33.18%26.46%20.22%27.89%18.35%16.90%
EBITDA
2,0121,9652,1141,8881,4451,151
EBITDA Margin
43.93%42.92%46.60%48.05%47.42%45.23%
D&A For EBITDA
194.14191.52181.07149.58111.8793.64
EBIT
1,8181,7731,9331,7391,3331,058
EBIT Margin
39.69%38.74%42.61%44.24%43.74%41.55%
Effective Tax Rate
13.01%12.67%12.65%12.65%11.54%14.25%
Revenue as Reported
4,5814,5774,5353,9303,0472,545
Advertising Expenses
-69.7173.7558.5434.3420.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.